X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42) 42
humans (37) 37
oncology (29) 29
female (20) 20
clinical neurology (19) 19
adult (18) 18
male (18) 18
middle aged (17) 17
aged (16) 16
prognosis (13) 13
survival (12) 12
treatment outcome (12) 12
young adult (12) 12
radiotherapy (10) 10
temozolomide (10) 10
article (9) 9
dacarbazine - analogs & derivatives (9) 9
brain neoplasms - drug therapy (8) 8
cancer (8) 8
chemotherapy (8) 8
combined modality therapy (8) 8
follow-up studies (8) 8
glioblastoma - drug therapy (8) 8
surgery (8) 8
abridged index medicus (7) 7
aged, 80 and over (7) 7
biomarkers (7) 7
brain neoplasms - pathology (7) 7
disease-free survival (7) 7
expression (7) 7
gliomas (7) 7
medical research (7) 7
therapy (7) 7
tumors (7) 7
antineoplastic agents - therapeutic use (6) 6
brain neoplasms - mortality (6) 6
dacarbazine - therapeutic use (6) 6
disease progression (6) 6
glioblastoma - diagnosis (6) 6
glioblastoma multiforme (6) 6
kaplan-meier estimate (6) 6
magnetic resonance imaging (6) 6
phase-ii (6) 6
radiation-therapy (6) 6
retrospective studies (6) 6
adolescent (5) 5
brain neoplasms - diagnosis (5) 5
brain neoplasms - surgery (5) 5
brain neoplasms - therapy (5) 5
clinical investigations (5) 5
clinical trials (5) 5
malignant glioma (5) 5
medicine & public health (5) 5
medicine, experimental (5) 5
medicine, research & experimental (5) 5
proportional hazards models (5) 5
radiation therapy (5) 5
research design (5) 5
survival rate (5) 5
animals (4) 4
biology (4) 4
biomarkers, tumor - analysis (4) 4
breast cancer (4) 4
cancer therapies (4) 4
concomitant (4) 4
glioblastoma - mortality (4) 4
glioblastoma - radiotherapy (4) 4
glioblastoma - therapy (4) 4
metastasis (4) 4
neoplasm staging (4) 4
neurology (4) 4
predictive value of tests (4) 4
prognostic-factors (4) 4
radiation (4) 4
radiotherapy, adjuvant (4) 4
reproducibility of results (4) 4
risk (4) 4
statistical methods (4) 4
survival analysis (4) 4
adjuvant temozolomide (3) 3
adults (3) 3
antineoplastic agents, alkylating - therapeutic use (3) 3
astrocytomas (3) 3
basic and translational investigations (3) 3
brain neoplasms - metabolism (3) 3
brain neoplasms - radiotherapy (3) 3
brain tumors (3) 3
cancer research (3) 3
cell lung-cancer (3) 3
chemotherapy, adjuvant (3) 3
clinical trials as topic - methods (3) 3
cohort studies (3) 3
computer simulation (3) 3
dacarbazine - administration & dosage (3) 3
data interpretation, statistical (3) 3
design (3) 3
enzastaurin (3) 3
extent of resection (3) 3
glioblastoma (3) 3
glioblastoma - metabolism (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neurosurgery, ISSN 0022-3085, 07/2011, Volume 115, Issue 1, pp. 3 - 8
Journal Article
Journal of Neurosurgery, ISSN 0022-3085, 01/2010, Volume 112, Issue 1, pp. 1 - 9
Object. Insular gliomas remain surgically challenging cases due to complex anatomy, including Surrounding vasculature and the relationship to functional... 
Extent of resection | Insula | Insular glioma | Glioma survival | SURGERY | REIL | ANATOMY | SERIES | extent of resection | glioma survival | EXTENT | ASTROCYTOMAS | GRADE | insula | insular glioma | CLINICAL NEUROLOGY
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4038 - 4038
BACKGROUND: Historically, one in five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT), a life-threatening... 
Journal Article
Clinical Trials, ISSN 1740-7745, 12/2017, Volume 14, Issue 6, pp. 621 - 628
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 09/2019, pp. 1 - 11
One-in-five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT). Given bleomycin-omission data with negative... 
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2013, Volume 105, Issue 22, pp. 1677 - 1683
Predictive biomarkers to guide therapy for cancer patients are a cornerstone of precision medicine. Discussed herein are considerations regarding the design... 
CELL LUNG-CANCER | CETUXIMAB | DESIGN | ONCOLOGY | RANDOMIZED PHASE-III | CONCOMITANT | RADIOTHERAPY | MAINTENANCE THERAPY | EGFR | CHEMOTHERAPY | ADJUVANT TEMOZOLOMIDE | Neoplasms - metabolism | Lung Neoplasms - drug therapy | Predictive Value of Tests | Receptor, Epidermal Growth Factor - genetics | Dacarbazine - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - metabolism | Molecular Targeted Therapy | Biomarkers, Tumor | Glioblastoma - radiotherapy | Dacarbazine - pharmacology | DNA Repair Enzymes - metabolism | Dacarbazine - analogs & derivatives | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Radiotherapy, Adjuvant | Interleukin-6 - metabolism | Lung Neoplasms - genetics | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Carcinoma, Renal Cell - metabolism | Sample Size | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Precision Medicine - trends | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Glioblastoma - drug therapy | Kidney Neoplasms - drug therapy | Methylation | Quinazolines - pharmacology | Care and treatment | Research | Biological markers | Identification and classification | Cancer | Index Medicus
Journal Article
Radiation Research, ISSN 0033-7587, 08/2014, Volume 182, Issue 2, pp. 252 - 252
As the immunotherapy of cancer comes of age, adding immunotherapeutic agents to radiation therapy has the potential to improve the outcomes for patients with a... 
Journal Article
Radiation Research, ISSN 0033-7587, 08/2014, Volume 182, Issue 2, pp. 252 - 252
As the immunotherapy of cancer comes of age, adding immunotherapeutic agents to radiation therapy has the potential to improve the outcomes for patients with a... 
Medical research | Therapy | Laboratories | Toxicity | Risk | Strategy | Radiation therapy | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2012, Volume 30, Issue 26, pp. 3304 - 3309
Efficient development of targeted therapies that may only benefit a fraction of patients requires clinical trial designs that use biomarkers to identify... 
CELL LUNG-CANCER | ISSUES | CETUXIMAB | PLACEBO | BENEFIT | ONCOLOGY | COLORECTAL-CANCER | Sample Size | Humans | Biomarkers - analysis | Treatment Outcome | Research Design | Molecular Targeted Therapy - methods | Clinical Trials, Phase II as Topic | Randomized Controlled Trials as Topic | To2 | Bios3 | Statistics in Oncology
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4362 - 4362
Purpose: Multiple myeloma (MM) is a plasma cell (PC) malignancy with an increasing incidence in the US. Epidemiological studies demonstrate a 2-3 fold higher... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5_suppl, pp. TPS17 - TPS17
TPS17 Background: Emerging studies suggest that breast cancer, particularly triple negative breast cancer (TNBC), may be sensitive to immunotherapy. However,... 
Journal Article
Modern Pathology, ISSN 0893-3952, 06/2015, Volume 28, Issue 6, pp. 778 - 786
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5_suppl, pp. 5 - 5
5 Background: Triple-negative breast cancer (TNBC) is an immunogenic breast cancer subtype, with a greater percentage of tumors containing tumor-infiltrating... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.